Sedana Medical AB (OSTO:SEDANA) Additional Paid-In Capital : kr1,226.4 Mil(As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB Additional Paid-In Capital?

Sedana Medical AB's quarterly additional paid-in capital declined from Sep. 2023 (kr1,226.4 Mil) to Dec. 2023 (kr1,226.4 Mil) but then stayed the same from Dec. 2023 (kr1,226.4 Mil) to Mar. 2024 (kr1,226.4 Mil).

Sedana Medical AB's annual additional paid-in capital increased from Dec. 2021 (kr1,222.4 Mil) to Dec. 2022 (kr1,226.4 Mil) but then stayed the same from Dec. 2022 (kr1,226.4 Mil) to Dec. 2023 (kr1,226.4 Mil).

Sedana Medical AB Additional Paid-In Capital Historical Data

The historical data trend for Sedana Medical AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Additional Paid-In Capital Chart

Sedana Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

605.70

613.92

1,222.40

1,226.44

Sedana Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,226.44	1,226.44	1,226.44	1,226.44	1,226.44

Sedana Medical AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sedana Medical AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sedana Medical AB (OSTO:SEDANA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

7D2A:Germany

Address

Vendevagen 89, Danderyd, SWE, SE-182 32

Website

https://www.sedanamedical.com

Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines